Skeletalis Bio
PrivateLast Round
Seed
Nov 17, 2025
Total Funding Raised
$8M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Skeletalis Bio is a biotechnology company developing a platform of targeted small-molecule therapeutics for treating osteoporosis.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Skeletalis Bio Comparables
Compare Skeletalis Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Apasomics | 88% | |
| Taithera, Inc. | 85% | |
| Mesentech Inc. | 85% |
Skeletalis Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Nov 17, 2025 |
Skeletalis Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| age1 | Seed |
| Pillar VC | Seed |
| KdT Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 17, 2025
Raised $8M in a Seed round.
Skeletalis Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Skeletalis Bio's valuation, stock price, and market status.
Is Skeletalis Bio a public or private company?
Skeletalis Bio is a private company.
What is the current stock price of Skeletalis Bio?
Skeletalis Bio is a private company with no public stock price. No recent secondary market data is available.
How much is Skeletalis Bio worth (valuation)?
Valuation information for Skeletalis Bio is not publicly available.
Can I buy Skeletalis Bio stock?
Skeletalis Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Skeletalis Bio's last funding round?
Skeletalis Bio's most recent funding round was Seed on November 17, 2025.
Who are the main investors in Skeletalis Bio?
Key investors in Skeletalis Bio include Pillar VC.
Will Skeletalis Bio IPO soon?
No public IPO plans have been announced for Skeletalis Bio.
How can I track Skeletalis Bio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Skeletalis Bio's secondary market activity and sign up for updates.